regeneron-pharmaceuticals
Delivered
Earnings Eye detected this earnings release on Tuesday, April 29, 2025 at 6:59:43 AM EDT and has distributed notifications to the Telegram channels listed at the bottom of the page.
Data sources leveraged on this page come from:
TradingViewCompany Information
- Ticker Symbol
- REGN
- Stock Exchange
- NASDAQ
- Sector
- Healthcare
- Industry
- Biotechnology
Stock Trading Snapshot
- Market Cap
- $66.4B
- Current Price
- $610.8600
- Previous Close
- $602.6400
- Price Change
- +1.3640%
- Average Volume
- 1M
- Volume Amount
- $951.9K
Financial Metrics
Earnings Per Share
- Estimate
- $8.621816
- Actual
- $8.220000
- Surprise
- $-0.401816
- Surprise %
- -4.6605%
Revenue
- Estimate
- $3.2B
- Actual
- $3B
- Surprise
- $-219M
- Surprise %
- -6.7427%
Notification Distribution
List of notifications sent to Telegram channels
Earnings releasedSent
4/29/25, 7:00 AM
REGN EPS Surprise:-4.66% Revenue Surprise: -6.74% EPS chain: $1.34B / $917.70M / $8.22(Est: $9.81) Revenue chain: $3.72B / $3.79B / $3.03B($3.48B) MA50/MA200: 642.68 / 848.55 52WeekRange: 525.99~1209.65 Close Price: 602.6400 Current Price: 610.8600 / +1.36%% Market Cap: $66.44B Sector: Healthcare - Biotechnology Release_date: 2025-04-29 10:59:43.857839+00:00 More details >>
Terminology
| Term | Definition |
|---|---|
| Ticker Symbol | A unique series of letters representing a publicly traded security. |
| Stock Exchange | The marketplace where securities are traded. |
| Sector | A category of the economy in which the company operates. |
| Industry | A specific category within a sector. |
| Market Cap | The total market value of a company's outstanding shares. |
| Current Price | The latest trading price of the stock. |
| Previous Close | The stock's closing price on the previous trading day. |
| Price Change | The percentage change in the stock's price from the previous close. |
| Average Volume | The average number of shares traded over a specific period. |
| Volume Amount | The total monetary value of shares traded. |
| Earnings Per Share | The portion of a company's profit allocated to each outstanding share. |
| Revenue | The total income generated by the company. |
| Estimate | The predicted value by analysts. |
| Actual | The reported value by the company. |
| Surprise | The difference between actual and estimated values. |
| Surprise % | The percentage difference between actual and estimated values. |